Hepatitis B and D: Interferon‐Based Therapy—For Clinical Trials or Standard of Care—Back to the Future?

Zillah Cargill, Harry L. A. Janssen, Tarik Asselah, Kosh Agarwal

Open source

DOI
10.1111/jvh.70259
Published
2026-11-03
Container
Journal of Viral Hepatitis
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jvh.70259,
  title = {Hepatitis B and D: Interferon‐Based Therapy—For Clinical Trials or Standard of Care—Back to the Future?},
  author = {Zillah Cargill and Harry L. A. Janssen and Tarik Asselah and Kosh Agarwal},
  year = {2026},
  journal = {Journal of Viral Hepatitis},
  doi = {10.1111/jvh.70259},
  url = {https://doi.org/10.1111/jvh.70259}
}

RIS

TY  - JOUR
TI  - Hepatitis B and D: Interferon‐Based Therapy—For Clinical Trials or Standard of Care—Back to the Future?
AU  - Zillah Cargill
AU  - Harry L. A. Janssen
AU  - Tarik Asselah
AU  - Kosh Agarwal
PY  - 2026
JO  - Journal of Viral Hepatitis
DO  - 10.1111/jvh.70259
UR  - https://doi.org/10.1111/jvh.70259
ER  - 

APA

Cargill, Z., Janssen, H. L. A., Asselah, T., & Agarwal, K. (2026). Hepatitis B and D: Interferon‐Based Therapy—For Clinical Trials or Standard of Care—Back to the Future?. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70259

Source records